CHAMPIONS ONCOLOGY, INC. — Form 10-Q
Filed September 11, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 5/100
What the filing says
Robert Brainin (CEO) and David Miller (CFO) provided standard Sarbanes-Oxley Section 302 and 906 certifications dated September 11, 2026 for the quarterly report ended July 31, 2026. Both officers certified that the 10-Q contains no untrue material statements, fairly presents financial condition and results of operations, and that disclosure controls and internal controls over financial reporting are effective. No material weaknesses, significant deficiencies, or fraud were disclosed.
Why this rating
Routine SOX certification exhibits; boilerplate compliance filing. No substantive business event disclosed.
See more from September 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.